(Q35225867)

7 August 2017

1 reference

title

Epstein-Barr virus in B lymphocytes: viral gene expression and function in latency (English)

1 reference

7 August 2017

Epstein-Barr Virus In B Lymphocytes: Viral Gene Expression and Function in Latency (English)

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

viral gene expression regulation

2 December 2023

main subject

Epstein–Barr virus

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312289

12 September 2022

1 reference

2

Strominger JL

1 reference

7 August 2017

3

Speck SH

1 reference

7 August 2017

R. P. Rogers

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312289

12 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1312289

12 September 2022

publication date

1 January 1992

1 reference

Advances in Cancer Research

7 August 2017

published in

1 reference

7 August 2017

volume

58

1 reference

7 August 2017

page(s)

1-26

1 reference

Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.

7 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes

2 December 2023

2

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B.

2 December 2023

3

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes

2 December 2023

4

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

2 December 2023

5

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus

2 December 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Construction and analysis of additional adenovirus substitution mutants confirm the complementation of VAI RNA function by two small RNAs encoded by Epstein-Barr virus

2 December 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2.

2 December 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus mRNAs produced by alternative splicing

2 December 2023

10

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

An Epstein-Barr virus transcription unit is at least 84 kilobases long

2 December 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas

2 December 2023

13

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance

2 December 2023

14

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation

2 December 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

2 December 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment

2 December 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.

2 December 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus RNA in Burkitt tumor tissue

2 December 2023

19

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2

2 December 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation

2 December 2023

22

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.

2 December 2023

27

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus

2 December 2023

28

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element

2 December 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein

2 December 2023

31

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2

2 December 2023

32

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21).

2 December 2023

33

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines

2 December 2023

34

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication

2 December 2023

36

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures

2 December 2023

37

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency

2 December 2023

40

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion

2 December 2023

41

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance

2 December 2023

42

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line

2 December 2023

43

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

The bcl-2 gene encodes a novel G protein

2 December 2023

44

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

2 December 2023

45

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen

2 December 2023

47

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

2 December 2023

48

27

2422

Henle

1967

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis

2 December 2023

49

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

A third viral nuclear protein in lymphoblasts immortalized by Epstein-Barr virus

2 December 2023

50

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family

2 December 2023

51

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Colonies of EBNA-positive cells in soft agar from peripheral leukocytes of infectious mononucleosis patients

2 December 2023

52

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus small RNA (EBER) genes: unique transcription units that combine RNA polymerase II and III promoter elements

2 December 2023

53

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

The short unique region of the B95-8 Epstein-Barr virus genome

2 December 2023

55

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

B cell activation and the establishment of Epstein-Barr virus latency

2 December 2023

56

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Organization of the Epstein-Barr virus DNA molecule. III. Location of the P3HR-1 deletion junction and characterization of the NotI repeat units that form part of the template for an abundant 12-O-tetradecanoylphorbol-13-acetate-induced mRNA transcr

2 December 2023

57

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus.

2 December 2023

59

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein–Barr virus

2 December 2023

62

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Viral latency and transformation: the strategy of Epstein-Barr virus

2 December 2023

64

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients

2 December 2023

65

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Protein kinase activity associated with a cell cycle regulated, membrane-bound Epstein-Barr virus induced early antigen

2 December 2023

67

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Highly localized tracks of specific transcripts within interphase nuclei visualized by in situ hybridization

2 December 2023

70

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth

2 December 2023

72

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Association of Epstein-Barr virus with thymic carcinoma

2 December 2023

73

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1.

2 December 2023

74

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines

2 December 2023

75

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael

2 December 2023

76

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael

2 December 2023

77

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis

2 December 2023

78

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference

2 December 2023

79

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

2 December 2023

80

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Site of Epstein-Barr virus replication in the oropharynx

2 December 2023

81

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants

2 December 2023

82

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains

2 December 2023

84

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection.

2 December 2023

86

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells

2 December 2023

88

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus and human diseases: recent advances in diagnosis

2 December 2023

89

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Absence, or low expression, of leukocyte adhesion molecules CD11 and CD18 on Burkitt lymphoma cells

2 December 2023

90

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Defective viral DNA in Epstein-Barr virus-associated oral hairy leukoplakia

2 December 2023

91

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex

2 December 2023

92

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes

2 December 2023

93

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus

2 December 2023

95

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus transcription in nasopharyngeal carcinoma

2 December 2023

96

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA.

2 December 2023

97

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region

2 December 2023

98

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.

2 December 2023

99

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Virology: Epstein–Barr virus in epithelium

2 December 2023

100

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Comparative studies on adult donor lymphocytes infected by EB virusin vivo orin vitro: Origin of transformed cells arising in co-cultures with foetal lymphocytes

2 December 2023

101

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

HLA-restricted T-cell recognition of Epstein–Barr virus-infected B cells

2 December 2023

102

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells

2 December 2023

104

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis

2 December 2023

105

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Quantitative Evaluation of Epstein-Barr-Virus-Infected Mononuclear Peripheral Blood Leukocytes in Infectious Mononucleosis

2 December 2023

106

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Bidirectional transcription of the Epstein-Barr virus major internal repeat

2 December 2023

107

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance

2 December 2023

109

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells

2 December 2023

113

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site

2 December 2023

116

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

2 December 2023

117

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Characterization of a latent protein encoded by the large internal repeats and the BamHI Y fragment of the Epstein-Barr virus (EBV) genome

2 December 2023

118

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Expression of EBNA-3 family in fresh B lymphocytes infected with Epstein-Barr virus

2 December 2023

119

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells

2 December 2023

121

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

A second site for Epstein-Barr virus shedding: the uterine cervix

2 December 2023

122

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Detection of a second widespread strain of Epstein-Barr virus

2 December 2023

123

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Mapping the X-linked lymphoproliferative syndrome

2 December 2023

125

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Analysis of the transcript encoding the latent Epstein-Barr virus nuclear antigen I: a potentially polycistronic message generated by long-range splicing of several exons

2 December 2023

126

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

An Epstein-Barr virus transcript from a latently infected, growth-transformed B-cell line encodes a highly repetitive polypeptide

2 December 2023

128

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

An intricate route to immortality

2 December 2023

129

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency

2 December 2023

131

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Stable expression in mouse cells of nuclear neoantigen after transfer of a 3.4-megadalton cloned fragment of Epstein-Barr virus DNA

2 December 2023

132

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro

2 December 2023

134

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells

2 December 2023

135

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Multipoint linkage mapping of the Xq25-q26 region in a family affected by the X-linked lymphoproliferative syndrome

2 December 2023

136

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells

2 December 2023

137

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein

2 December 2023

138

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Overexpression of the human BCL-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells

2 December 2023

140

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus RNA VII: size and direction of transcription of virus-specified cytoplasmic RNAs in a transformed cell line

2 December 2023

142

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

2 December 2023

144

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

2 December 2023

146

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

2 December 2023

147

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

2 December 2023

148

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Major EB virus-specific cytoplasmic transcripts in a cellular clone of the HR-1 Burkitt lymphoma line during latency and after induction of viral replicative cycle by phorbol esters

2 December 2023

149

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes

2 December 2023

150

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes

2 December 2023

151

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection

2 December 2023

152

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Persistence of Epstein-Barr virus in the parotid gland

2 December 2023

153

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Chromosome deletion of Xq25 in an individual with X-linked lymphoproliferative disease

2 December 2023

154

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Establishment and characterization of two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus and derived from nasopharyngeal carcinomas

2 December 2023

155

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals

2 December 2023

156

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

The Epstein-Barr virus:host balance in acute infectious mononucleosis patients receiving acyclovir anti-viral therapy

2 December 2023

157

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers

2 December 2023

158

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

2 December 2023

159

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus receptors on human pharyngeal epithelia

2 December 2023

160

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes

2 December 2023

161

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene

2 December 2023

162

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60288-2

2 December 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1312289

12 September 2022

1 reference